Abstract:
Introduction. Myocardial ischemia is a leader in the structure of cardiovascular morbidity and
mortality. The results of the study of the prevalence of cardiovascular risk factors and the
influence of modifiable risk factors could decrease the mortality caused by this disease.
Metabolic disorders such as hyperglycemia, dyslipidemia and insulin resistance affect arterial
function and increase their susceptibility to atherosclerosis, manifesting including increased
frequency of cardiovascular complications, both acute and chronic.
